A Phase 3 interventional study of Olanzapine, Omega 3, Vitamin E+C in Schizophrenia, sponsored by Augusta University. Terminated at 1 site in United States. Open to participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2012-10-24.
Sponsored by Augusta University · Phase 3, Interventional, and Prevention
This research study helps to demonstrate that adding vitamins and fats (nutritional supplements) to a diet will help reduce body weight and improve the lipid profile. This will be done by examining the body weight and chemicals in the blood. The chemicals are the result of the brain using the fat that subjects eat in their diet. Some medications may also change the amount of these chemicals in a person's blood.
To demonstrate that supplementation of antioxidants and omega-3 fatty acids will improve clinical outcome including cognitive performance in olanzapine treated patients.
3,471 studies on the registry are indexed under Schizophrenia; 472 are open to participants now.
This study's enrollment of 20 is below the median of 70 across 2,872 interventional studies indexed under Schizophrenia.
Browse Schizophrenia studies →Augusta University is the lead sponsor of 177 studies on the registry; 24 are open to participants now.
Of its 10 completed or terminated interventional studies of FDA-regulated products, 3 (30%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Drug: Olanzapine, Omega 3, Vitamin E+C
Drug: Olanzapine, Omega 3, Vitamin E+C
Drug: Olanzapine, Omega 3, Vitamin E+C
No adverse event nor SAE noted.
PANSS
Study completed in 2006. PI no longer with the institution. Study was closed accordingly to the HAC.
Time frame: 2003-2006
BMI
BMI match height and weight.
Time frame: 2003-2006
Blood samples
Samples analyzed, PI analyzed and published. PI no longer with the institution.
Time frame: 2003-2006
Cognitive assessments
BACS assessment. Data analyzed and published by the PI.
Time frame: 2003-2006
This study is terminated, as verified in Oct 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Augusta University